Northern Light Pharmaceuticals AB
Innovative drugs for cancer, inflammatory pain, and neurological disorders
This article was originally published in Start Up
Executive Summary
Swedish start-up Northern Light Pharmaceuticals AB spun out of AstraZeneca AB with a portfolio of early-stage products designed to meet the aging population’s unmet needs in treating cancer, inflammatory pain, and neurological disorders.
You may also be interested in...
Biopharma In Sweden: A Comfortable Climate For Start-Ups
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups.
Biopharma In Sweden: A Comfortable Climate For Start-Ups
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups. Profiles of Northern Light Pharmaceuticals AB, Sigrid Therapeutics, and Swecure AB.
Gadeta BV: Using T-Cells To Target Metabolic Dysregulation In Cancer
Emerging Company Profile: Gadeta, a Dutch spin-out from University Medical Centre Utrecht, launched earlier this year to develop modified T-cell-based therapies that target metabolic dysregulation in solid and hematological malignancies.